ストックスクリーナーアプリを入手
104.49
1.39%
1.43
プレマーケット:
105.49
1.00
+0.96%
Abbott Laboratories (ABT) 最新ニュース
FRAUD AND MANIPULATION—N.D. Ill.: Abbott did not commit securities fraud over tainted baby formula - VitalLaw.com
Abbott (ABT) Lands Exclusive Rights To FDA Approved Blood Based CRC Test - Yahoo Finance
Freenome went public for $300 million, then scored a huge victory with colorectal cancer test - The Business Journals
Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth? - Yahoo Finance
Federal Judge Dismisses Abbott Shareholder Lawsuit Over 2022 Infant Formula Recall - Law Commentary
Abbott Labs Shakes Investor Suit Over 2022 Infant Formula Recall - Bloomberg Law News
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott - Fierce Biotech
FDA approves Freenome's blood test for colorectal cancer screening - Reuters
Is Abbott Stock Attractive After Its Earnings and Guidance Update? - The Globe and Mail
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. - BioSpace
Abbott (ABT) Introduces FDA-Approved SimpleScreen CRC for Colore - GuruFocus
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth - Yahoo Finance
Zacks Investment Ideas feature highlights: General Motors, Abbott Laboratories and Johnson & Johnson - The Globe and Mail
Why Is Abbott Laboratories (NYSE:ABT) a Blue-Chip Stock to Watch? - Kalkine Media
Abbott stock trades steady as investors weigh recent earnings and medical device growth - Ad-hoc-news.de
If I Were Starting My Portfolio From Scratch Today, This Is the First ETF I'd Buy - The Motley Fool
Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings - Ad-hoc-news.de
PRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation Under Investigation for Data Breach of Patient Records - Los Angeles Downtown News
Abbott Laboratories (ABT) Could Be 14% Undervalued On Mixed Earnings And Growth Focus - simplywall.st
Abbott defeats shareholder lawsuit over 2022 infant formula recall | Business Information & News | FE - Westlaw Today
Health News Roundup: Abbott Wins Lawsuit, Measles Surge in the US, and More Updates - Devdiscourse
Abbott Beats 'Supersized' Investor Suit Over Formula Recall - Law360
Abbott Wins 7th Circ. Fight Over Baby Formula Warning - Law360
Patient Sues Abbott Labs, Exact Sciences in Data Theft - BankInfoSecurity
Abbott Notches Appellate Win in Bellwether Infant Formula Case - news.bloombergtax.com
Abbott defeats shareholder lawsuit over 2022 infant formula recall - Reuters
Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher - TradingView
FreeStyle Libre 3 Class Action Lawsuit Alleges Abbott Sold Defective Glucose Monitors - AboutLawsuits.com
Medtech Stocks Have Gotten Slammed. Why Abbott, Danaher, 4 More Are Bargains. - Barron's
Abbott Laboratories stock trades steady as diagnostics and medical devices support earnings momentum - AD HOC NEWS
Abbott Laboratories and Exact Sciences Corp Under Investigation for Data Breach of Patient Records - Schubert Jonckheer & Kolbe
Abbott Labs Accused Of Lax Security Over Shinyhunters Hack - Law360
Abbott Stock And 2 Dividend Ideas For Retirement Income - simplywall.st
ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now? - TradingView
Abbott Faces Spine Stimulator Lawsuit Brought Jointly by 17 Injured Patients - AboutLawsuits.com
Abbott Laboratories (NYSE:ABT) Faces A Profit Test - Kalkine Media
Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating - marketscreener.com
Same Industry, Less Money: What Boston Scientific and ResMed Offer That Abbott Laboratories Does Not - Trefis
Abbott Laboratories (ABT) Is Up 12.7% After Revenue Rises But Earnings Shrink In Q2 2026 - simplywall.st
Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value? - Yahoo Finance
Abbott Laboratories stock holds gains after strong diagnostics and medical devices momentum - Ad-hoc-news.de
Abbott Laboratories (ABT) Stock Forecasts - Yahoo Finance
Abbott (NYSE:ABT) Faces A Crucial Valuation Test - Kalkine Media
Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating - marketscreener.com
Cancer Diagnostics Breached At Abbott As 2026 Medtech Cyberattack Run Continues - insights.citeline.com
Abbott (ABT) Stock May Be 32% Undervalued As Legal Overhang Fades - simplywall.st
Abbott Laboratories stock steadies as medical devices and diagnostics underpin growth - Ad-hoc-news.de
Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch
Patients sue diagnostics company over data breach - Courthouse News
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories - Yahoo Finance
Abbott Is A Leader Who Cares About Hoosiers And Animals - InkFreeNews.com
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Abbott Confirms Unauthorized Access to Cancer Diagnostics Systems - cyberpress.org
NewsAbbott Investigates Cybersecurity Incidents After Hackers Claim Data Breach - teiss
Lobbying Update: $1,150,000 of ABBOTT LABORATORIES lobbying was just disclosed - Quiver Quantitative
Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen - Ad-hoc-news.de
Craneware, Abbott Probe Separate Health Data Theft Incidents - BankInfoSecurity
Abbott Laboratories (NYSE:ABT) Faces A Major Medical Device Growth Test - Kalkine Media
Healthcare giant Abbott probes two cyber incidents amid extortion claims - Security Boulevard
ShinyHunters hit medial giant Abbott, disrupting cancer drug research and more - Yahoo Tech
Abbott Laboratories (ABT) Gets a Buy from Raymond James - The Globe and Mail
Abbott Investigating Cyberattack Claims From Two Threat Actors - The HIPAA Journal
Abbott Laboratories investigates 2 separate cyber incidents - SC Media
Fairlife dairy cyberattack, ACR Stealer surge, Abbott Labs incidents - LinkedIn
Benchmark reiterates Buy on Abbott Labs stock, cites guidance raise - Investing.com
1.97%
大文字化:
|
ボリューム (24 時間):